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Moyamoya disease is an idiopathic non-progressive, non-atherosclerotic, and non-inflammatory vasculo-occlusive disease commonly affecting the supraclinoid 
internal carotid artery (ICA) with resultant secondary changes which 
may include infarcts, ischemia, and multiple collaterals within the 
brain [1]. Moyamoya disease derives its name from the Japanese 
which means the “puff of smoke.” It leads to characteristic intracranial 
vascular changes. Moyamoya is a disease of children and young 
people with a female preponderance of 1:2 (male:female ratio) and 
a bimodal age distribution of 10 years and 30–40 years of age. The 
term “Moyamoya disease” should not be confused with Moyamoya 
syndrome where there are numerous list of causes including blood 
dyscrasias including sickle cell disease, polycythemia vera, infections, 
connective tissue disorders, phakomatosis, atherosclerosis, Marfan’s 
syndrome, and Ehler-Danlos syndrome [1].
We report a case of 5-year-old female child who presented 
with a history of fall and weakness of the left upper limb and 
diagnosed as Moyamoya disease with typical imaging findings.
CASE REPORT
A 5-year-old female child presented to our emergency department 
with a history of headache, fall, and weakness of the left upper 
limb for 2 days duration. She had similar history 6 months back 
for which she was treated symptomatically by a local doctor. The 
headache was moderate in intensity with no diurnal variation and 
this was followed by dizziness and speech abnormalities. Her 
sensorium was normal with no history of fever, seizures, head 
injury, or sinusitis or visual disturbances. No neurocutaneous 
markers including skin pigmentations and angiomas were 
observed. Her general motor milestones were normal with normal 
development and no similar history was noted within the family.
On examination, her pulse rate was 80/min, BP 130/80 mmHg, 
temperature 98.5 Fahrenheit, and respiratory rate of 20/min. Her 
gait was hemiplegic with reduced power (2/5) in the left upper 
and lower limb, and plantar reflex was extensor on the left 
side with exaggerated reflexes. Cerebral spinal fluid analysis 
and peripheral smear were normal with normal hemogram and 
biochemical studies including renal and liver function tests.
On magnetic resonance imaging (MRI), ischemic changes 
were noted in the bilateral frontoparietal white matter. No evidence 
of acute infarcts (restrictions on diffusion-weighted imaging 
[DWI] and reduced apparent diffusion coefficient [ADC] values), 
and hemorrhage (blooming on gradient images) were observed 
(Fig. 1). On T2W images, multiple tiny dots/hypointensities were 
noted in the basal cisterna and Sylvian fissures representing dilated 
perforator vessels collaterals (Fig. 2). On MR angiogram, typical 
“puff of smoke” appearance was noted, with severe stenosis and 
occlusion of the bilateral supraclinoid ICA (Figs. 3 and 4).
A final diagnosis of Moyamoya was considered and the 
patient was treated symptomatically with aspirin 5 mg/kg for 
which she showed a slight improvement. Following symptomatic 
treatment, a superficial temporal artery-middle meningeal artery 
anastomosis was considered, following which, the patient showed 
a significant progressive improvement.
DISCUSSION
The vasculo-occlusive disease, Moyamoya affects the supraclinoid 
ICA and has unknown etiology. However, in a study done by 
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Bang et al., they reported that genetic and environmental factors 
play a role in the development of the disease. These factors cause 
changes in the cytokines related to angiogenesis like caveolin 
which is a plasma membrane protein [2].
Clinically, the patients presented with ischemic symptoms 
and transient ischemic attacks including limb weakness, 
frequent falls, slurring of speech, difficulty in swallowing, 
and headaches. On MRI, multiple infarcts with restrictions 
on DWI and reduced ADC may be seen. Ischemic changes, 
gliosis, and Wallerian degeneration may be seen. On T2W 
images, multiple tiny flow voids representing the collaterals of 
the perforator vessels may be seen. On MRA, a classical puff 
of smoke due to collaterals from perforator vessels of multiple 
correspondence analysis and principal component analysis 
may be seen. There may be unilateral or bilateral occlusion 
of the distal supraclinoid ICA [3]. On angiogram, the same 
findings are seen.
Grading of the Moyamoya disease on the basis of severity as 
proposed by Suzuki and Takaku [4], it includes the following: 
Grade 1: Forking of ICA, Grade 2: Initiation of Moyamoya, 
Grade 3: Intensification of Moyamoya, Grade 4: Minimization 
of Moyamoya, Grade 5: Reduction of Moyamoya, and Grade 6: 
Disappearance of Moyamoya patterns are seen. In Grade 6, 
there is a disappearance of “puff of smoke pattern” with 
collateralization of intracranial circulation by external carotid 
artery (ECA).
Treatment is usually surgical and pharmacological treatment 
includes control of hypertension and the antiplatelet agents 
may be given. Neurological rehabilitation and physiotherapy 
are supportive in case of infarcts. The various surgeries for 
Moyamoya disease include encephalomyosynangiosis (EMS), 
encephaloduroarteriosynangiosis, multiple burr holes for the 
development of collaterals from the scalp, and bypass procedures 
from the ECA and superficial temporal arteries [5-7]. Caldarelli 
et al. conducted a study on nine patients with Moyamoya disease 
and reported that if EMS surgery is done before significant 
cerebral damage occurs, it is very useful to stop the disease 
progression [8].
CONCLUSION
MRI with MR angiogram plays an important role in the diagnosis 
of Moyamoya disease, as well as, in the management and surgical 
planning of anastomosis.
Figure 2: Axial T2W magnetic resonance image showing multiple 
flow voids in the basal cisterna (arrow) representing dilated 
collateral vessels
Figure 4: Magnetic resonance angiogram image showing severe 
stenosis of the bilateral supraclinoid internal carotid artery (arrows) 
with typical “puff of smoke” appearance
Figure 1: (a) Axial fluid attenuation inversion recovery (FLAIR) 
image showing ischemic changes in bilateral frontal (arrow) and 
parietal white matter; (b) Axial FLAIR image showing gliosis 
in the left parietooccipital lobe and lacunar infarcts in the left 
capsuloganglionic region
a b
Figure 3: (a) Magnetic resonance (MR) angiogram source image 
showing multiple collaterals in basal cisterna (arrow), (b) T1W post-
contrast MR image showing multiple collaterals in thalami (arrow)
a b
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